1. Home
  2. PTLE vs ATNM Comparison

PTLE vs ATNM Comparison

Compare PTLE & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTLE
  • ATNM
  • Stock Information
  • Founded
  • PTLE 2013
  • ATNM 2000
  • Country
  • PTLE Singapore
  • ATNM United States
  • Employees
  • PTLE N/A
  • ATNM N/A
  • Industry
  • PTLE Oil Refining/Marketing
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTLE Energy
  • ATNM Health Care
  • Exchange
  • PTLE Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • PTLE 130.7M
  • ATNM 56.5M
  • IPO Year
  • PTLE 2024
  • ATNM N/A
  • Fundamental
  • Price
  • PTLE $12.19
  • ATNM $1.26
  • Analyst Decision
  • PTLE
  • ATNM Strong Buy
  • Analyst Count
  • PTLE 0
  • ATNM 4
  • Target Price
  • PTLE N/A
  • ATNM $8.75
  • AVG Volume (30 Days)
  • PTLE 976.8K
  • ATNM 414.8K
  • Earning Date
  • PTLE 02-21-2025
  • ATNM 11-14-2024
  • Dividend Yield
  • PTLE N/A
  • ATNM N/A
  • EPS Growth
  • PTLE N/A
  • ATNM N/A
  • EPS
  • PTLE 0.03
  • ATNM N/A
  • Revenue
  • PTLE $108,126,091.00
  • ATNM $81,000.00
  • Revenue This Year
  • PTLE N/A
  • ATNM $186.10
  • Revenue Next Year
  • PTLE N/A
  • ATNM $19,248.94
  • P/E Ratio
  • PTLE $397.33
  • ATNM N/A
  • Revenue Growth
  • PTLE 36.47
  • ATNM N/A
  • 52 Week Low
  • PTLE $2.01
  • ATNM $1.10
  • 52 Week High
  • PTLE $12.28
  • ATNM $10.24
  • Technical
  • Relative Strength Index (RSI)
  • PTLE N/A
  • ATNM 46.03
  • Support Level
  • PTLE N/A
  • ATNM $1.16
  • Resistance Level
  • PTLE N/A
  • ATNM $1.29
  • Average True Range (ATR)
  • PTLE 0.00
  • ATNM 0.10
  • MACD
  • PTLE 0.00
  • ATNM 0.02
  • Stochastic Oscillator
  • PTLE 0.00
  • ATNM 66.67

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, primarily serving the Asia Pacific market. As a bunker facilitator, the Group's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers in a timely manner; and handling disputes, mainly in relation to quality and quantity issues on marine fuel, if any.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: